- Home
- RMBI vs ACET Comparison
RMBI vs ACET Comparison
Compare RMBI & ACET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMBI
- ACET
- Stock Information
- Founded
- RMBI 1887
- ACET 1947
- Country
- RMBI United States
- ACET United States
- Employees
- RMBI N/A
- ACET N/A
- Industry
- RMBI Major Banks
- ACET Biotechnology: Pharmaceutical Preparations
- Sector
- RMBI Finance
- ACET Health Care
- Exchange
- RMBI Nasdaq
- ACET Nasdaq
- Market Cap
- RMBI 128.8M
- ACET 111.9M
- IPO Year
- RMBI 2019
- ACET N/A
- Fundamental
- Price
- RMBI $13.25
- ACET $0.66
- Analyst Decision
- RMBI
- ACET Buy
- Analyst Count
- RMBI 0
- ACET 4
- Target Price
- RMBI N/A
- ACET $8.50
- AVG Volume (30 Days)
- RMBI 17.7K
- ACET 1.9M
- Earning Date
- RMBI 10-23-2025
- ACET 11-05-2025
- Dividend Yield
- RMBI 4.55%
- ACET N/A
- EPS Growth
- RMBI 21.88
- ACET N/A
- EPS
- RMBI 1.06
- ACET N/A
- Revenue
- RMBI $44,970,551.00
- ACET N/A
- Revenue This Year
- RMBI N/A
- ACET N/A
- Revenue Next Year
- RMBI N/A
- ACET N/A
- P/E Ratio
- RMBI $12.44
- ACET N/A
- Revenue Growth
- RMBI 6.42
- ACET N/A
- 52 Week Low
- RMBI $11.37
- ACET $0.45
- 52 Week High
- RMBI $15.24
- ACET $1.19
- Technical
- Relative Strength Index (RSI)
- RMBI 45.07
- ACET 37.42
- Support Level
- RMBI $12.77
- ACET $0.63
- Resistance Level
- RMBI $13.89
- ACET $0.70
- Average True Range (ATR)
- RMBI 0.38
- ACET 0.06
- MACD
- RMBI 0.03
- ACET -0.01
- Stochastic Oscillator
- RMBI 41.96
- ACET 19.90
About RMBI Richmond Mutual Bancorporation Inc.
Richmond Mutual Bancorp Inc is a United States-based banking company. Its principal business consists of attracting deposits from the general public & brokered deposits and investing those funds predominantly in loans secured by commercial and multi-family real estate, first mortgages on owner-occupied, one-to four-family residences, a variety of consumer loans, direct financing leases, and commercial and industrial loans. The company has one reportable segment which is Community Banking.
About ACET Adicet Bio Inc.
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.